133 related articles for article (PubMed ID: 38278412)
1. The role of high mobility group AT-hook 1 in viral infections: Implications for cancer pathogenesis.
Akade E; Jalilian S
Int J Biochem Cell Biol; 2024 Apr; 169():106532. PubMed ID: 38278412
[TBL] [Abstract][Full Text] [Related]
2. High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.
Wang L; Zhang J; Xia M; Liu C; Zu X; Zhong J
Int J Biol Sci; 2022; 18(11):4414-4431. PubMed ID: 35864955
[TBL] [Abstract][Full Text] [Related]
3. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
Liau SS; Rocha F; Matros E; Redston M; Whang E
Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
[TBL] [Abstract][Full Text] [Related]
4. HMGA1 interacts with β-catenin to positively regulate Wnt/β-catenin signaling in colorectal cancer cells.
Xing J; Cao G; Fu C
Pathol Oncol Res; 2014 Oct; 20(4):847-51. PubMed ID: 24696416
[TBL] [Abstract][Full Text] [Related]
5. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
6. HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer.
Akaboshi S; Watanabe S; Hino Y; Sekita Y; Xi Y; Araki K; Yamamura K; Oshima M; Ito T; Baba H; Nakao M
Am J Pathol; 2009 Oct; 175(4):1675-85. PubMed ID: 19729480
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group AT-Hook 1 mediates the role of nuclear factor I/X in osteogenic differentiation through activating canonical Wnt signaling.
Wu X; Wang X; Shan L; Zhou J; Zhang X; Zhu E; Yuan H; Wang B
Stem Cells; 2021 Oct; 39(10):1349-1361. PubMed ID: 34028135
[TBL] [Abstract][Full Text] [Related]
8. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
10. The high mobility group AT-hook 1 protein stimulates bovine herpesvirus 1 productive infection.
Zhu L; Jones C
Virus Res; 2017 Jun; 238():236-242. PubMed ID: 28684158
[TBL] [Abstract][Full Text] [Related]
11. Potential Role for a β-Catenin Coactivator (High-Mobility Group AT-Hook 1 Protein) during the Latency-Reactivation Cycle of Bovine Herpesvirus 1.
Zhu L; Workman A; Jones C
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003484
[TBL] [Abstract][Full Text] [Related]
12. High mobility group A1 and cancer: potential biomarker and therapeutic target.
Shah SN; Resar LM
Histol Histopathol; 2012 May; 27(5):567-79. PubMed ID: 22419021
[TBL] [Abstract][Full Text] [Related]
13. HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancer.
Han X; Cao Y; Wang K; Zhu G
Biomed Pharmacother; 2016 Aug; 82():312-8. PubMed ID: 27470368
[TBL] [Abstract][Full Text] [Related]
14. High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein.
Shen Z; Wu J; Gao Z; Zhang S; Chen J; He J; Guo Y; Deng Q; Xie Y; Liu J; Zhang J
Nucleic Acids Res; 2022 Feb; 50(4):2157-2171. PubMed ID: 35137191
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
16. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
[TBL] [Abstract][Full Text] [Related]
17. HMGA1 stimulates MYH9-dependent ubiquitination of GSK-3β via PI3K/Akt/c-Jun signaling to promote malignant progression and chemoresistance in gliomas.
Que T; Zheng H; Zeng Y; Liu X; Qi G; La Q; Liang T; Li Z; Yi G; Zhang S; Li J; Nie J; Tan JE; Huang G
Cell Death Dis; 2021 Dec; 12(12):1147. PubMed ID: 34887392
[TBL] [Abstract][Full Text] [Related]
18. HMGA1 in cancer: Cancer classification by location.
Wang Y; Hu L; Zheng Y; Guo L
J Cell Mol Med; 2019 Apr; 23(4):2293-2302. PubMed ID: 30614613
[TBL] [Abstract][Full Text] [Related]
19. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.
Schuldenfrei A; Belton A; Kowalski J; Talbot CC; Di Cello F; Poh W; Tsai HL; Shah SN; Huso TH; Huso DL; Resar LM
BMC Genomics; 2011 Nov; 12():549. PubMed ID: 22053823
[TBL] [Abstract][Full Text] [Related]
20. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
Chang X; Liu J; Yang Q; Gao Y; Ding X; Zhao J; Li Y; Liu Z; Li Z; Wu Y; Zuo D
Biochem Pharmacol; 2023 Jun; 212():115582. PubMed ID: 37146833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
